SEC Filing | The Cronos Group

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Weigensberg Arye

(Last)

(First)

(Middle)

111 PETER STREET, SUITE 300

(Street)

TORONTO

M5V 2H1

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/09/2022

3. Issuer Name and Ticker or Trading Symbol
Cronos Group Inc. [ CRON ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
See Remarks

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
COMMON SHARES	5,505	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
RESTRICTED STOCK UNITS	⁽¹⁾	⁽¹⁾	COMMON SHARES	38,048	⁽²⁾	D
COMMON SHARE OPTION (right to buy)	⁽³⁾	08/12/2024	COMMON SHARES	2,031	17.68⁽⁴⁾	D

Explanation of Responses:

1. The restricted share units ("RSUs") consist of the following: (1) 3,064 unvested RSUs vesting in substantially equal annual installments, with the second of three scheduled vesting dates to occur on December 17, 2022, (2) 7,944 unvested RSUs vesting in substantially equal annual installments with the second of three scheduled vesting dates to occur on May 25, 2022, and (3) 27,040 unvested RSUs vesting in three substantially equal annual installments beginning on May 12, 2023, in each case, subject to continued employment through each applicable date.

2. Each RSU represents a contingent right to receive one common share of the Company.

3. The options were granted August 12, 2019 and vest in quarterly installments over a four-year period.

4. The exercise price is expressed in Canadian dollars.

Remarks:

Senior Vice President, Head of Research and Development. Exhibit List: Exhibit 24 - Power of Attorney.

	Aaron B. Werner, as attorney-in-fact for Arye Weigensberg	08/18/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Exhibit 24

Authorization and Designation to Sign and File  Section 16 Reporting Forms

The undersigned, an executive officer of Cronos Group Inc., a corporation  incorporated under the Business Corporations Act (British Columbia) (the "Company"),  does hereby authorize and designate Robert Madore, Terry Doucet or Aaron Werner,  each with right to substitute and resubstitute, but for only so long as each of them is an  employee of the Company, to sign and file on his behalf the application for the required  Securities and Exchange Commission ("SEC”") electronic CIK/CCC codes and any and  all Forms 3, 4 and 5 and Forms 144 relating to equity securities of the Company with the  SEC pursuant to the requirements of Section 16 of the Securities Exchange Act of 1934  ("Section 16") and Rule 144 under the Securities Act of 1933, as amended.  This  authorization, unless earlier revoked in writing, shall be valid until the undersigned's  reporting obligations under Section 16 and Rule 144 with respect to equity securities of  the Company shall cease.  All prior such authorizations are hereby revoked.

IN WITNESS WHEREOF, the undersigned has executed this Authorization and  Designation this __July ___ day of ________21________, 2022.

/s/Arye Weigensberg
Arye Weigensberg